News & Views
Lödige Strengthens Indian Joint Venture Bectochem Loedige Process Technology
Dec 04 2019 Read 800 Times
Gebr. Lödige Maschinenbau GmbH is currently expanding its engineering and production capacities for coating, mixing, granulating and drying as well as the handling units required for this process in India. This represents an expansion of the globally active company’s successful joint venture with the Indian company Bectochem, a leading manufacturer of pharmaceutical process technology.
The Mumbai-based joint venture, Bectochem Loedige Process Technology (BLPT), of which Lödige holds a share of 51%, was established in April 2013. Since then this strategic collaboration has undergone steady further development: The portfolio of BLPT includes machines for the pharmaceutical, food and chemical industry. In total, this collaboration has supplied companies in India and its neighbouring countries with over 300 pharmaceutical processing systems to date, significantly more than 100 of which were tablet coaters. This has allowed Lödige to enter a regional market which is practically inaccessible in any other way. In return, Bectochem can supply its customers with systems built according to German technological and quality standards.
“This kind of model is still rather uncommon for medium-sized German companies,” explained Lödige Director Dr Dirk Sunderer. “But we are confident in our decision. That is why we will increasingly integrate engineering and production services from India in our core processes. For instance, some products of our portfolio will be produced entirely by BLPT in the future. We expect this to give us a significant cost advantage over our competitors, especially where price-sensitive products are concerned,” he added.
The decision to strengthen the company’s commitment to India is part of a strategic reorientation: Lödige is currently undergoing a transformation from a conventional machine building company to a provider of integrated process engineering solutions with the aim of becoming a future-proof solution & service provider.
“The development from a mostly production-oriented company to an engineering company requires us to expand our own engineering capacities,” Sunderer said, describing the requirements of this transformation process. “Production services and, in the future, also engineering services will increasingly be purchased both from the domestic and the foreign market, with basic engineering, R&D and our core competencies in the area of production technology remaining at our headquarters in Paderborn, Germany.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...
View all digital editions
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE
Jan 29 2020 Tokyo, Japan
Feb 03 2020 Dubai, UAE
Feb 12 2020 Tokyo, Japan